ReShape Lifesciences RSLSD 深 沪
等待开盘 04-01 09:30:00 美东时间
0.00
0.000
NaN.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.00
- 总市值 0
- 52周最高 441000.00
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 7.80
- 委 比 0.00%
- 总股本 0
- 历史最高 529200.00
- 量 比 0
- 振 幅 NaN.00%
- 历史最低 7.80
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND
Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on August 15, 2025Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting
2025-08-12 21:55
ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Effective August 15, 2025
ReShape Lifesciences Inc. has announced that its shareholders have approved all necessary proposals for the merger with Vyome Therapeutics. The merger is expected to become effective on August 15, 202...
2025-08-08 05:02
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
ReShape Lifesciences will host its first Lap-Band® Surgeon Summit from August 1-3, 2025, in Nashville, featuring Dr. Christine Ren-Fielding as director. The event will focus on the benefits of the Lap-Band® System, including the new 2.0 FLEX, and advancements in GLP-1 therapies. The company aims to enhance patient outcomes and expand access to these weight management tools through collaboration with leading surgeons.
2025-07-22 12:31
'ReShape Lifesciences Granted U.S. Patent Related To An Intragastric Balloon System'
https://reshapelifesciences.gcs-web.com/news-releases/news-release-details/reshape-lifesciencesr-granted-us-patent-related-intragastric
2025-07-08 22:26
ReShape Lifesciences Loans $200K to Vyome Therapeutics
ReShape Lifesciences ( ($RSLS) ) has shared an announcement. On June 27, 2025, ...
2025-07-04 04:33
ReShape Lifesciences Inc. Announces $200,000 Loan Agreement with Vyome Therapeutics to Support Upcoming Merger
ReShape Lifesciences Inc. has entered into a promissory note agreement with Vyome Therapeutics, Inc., as disclosed in a recent Form 8-K filing. Under this agreement, ReShape will provide a loan of $20...
2025-07-04 04:06
ReShape Lifesciences Granted U.S. Patent 12,350,179 Entitled "Intragastric Device."
The patent, related to the Company's application 18/241,151 and notice of allowance received in April, covers claims for an intragastric balloon system, comprising a swallowable capsule with a self-sealing fill valve and
2025-07-01 20:34
ReShape Lifesciences regains Nasdaq compliance
ReShape Lifesciences (NASDAQ:RSLS) has regained compliance with Nasdaq requiring at least $2.5M in stockholders’ equity. Source: Press release More on ReShape Lifesciences ReShape Lifesciences Inc. (R...
2025-06-27 21:53
ReShape Lifesciences Announces Strategic Headcount Reduction; Issues Update On Merger Agreement With Vyome Therapeutics And Asset Purchase Agreement With Biorad Medisys
Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll ExpensesAgreements Progress Toward Completion; Shareholder Meeting Scheduled for July 24, 2025IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) --
2025-06-26 20:33
ReShape Lifesciences shares are trading higher after the company announced it was granted an institutional patent from the Australian Patent Office for its Diabetes Neuromodulation technology.
ReShape Lifesciences shares are trading higher after the company announced it w...
2025-06-25 21:12
